Gossamer Bio (GOSS) Other Non Operating Income (2019 - 2026)

Gossamer Bio's Other Non Operating Income history runs 8 years deep, the most recent figure standing at $603000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 77.02% year-over-year to $603000.0; the TTM figure through Mar 2026 stood at $7.3 million (down 47.45% YoY), while the FY2025 annual figure was $9.3 million, down 33.75% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $603000.0, down from $1.0 million in the prior quarter.
• The five-year high for Other Non Operating Income was $6.5 million in Q2 2023, with the low at -$332000.0 in Q3 2022.
• The 5-year median for Other Non Operating Income is $2.7 million (2025), against an average of $2.4 million.
• Peak annual rise in Other Non Operating Income reached 1766.67% in 2022, while the deepest fall reached 388.7% in 2022.
• Gossamer Bio's Other Non Operating Income stood at $1.5 million in 2022, then soared by 161.54% to $3.8 million in 2023, then advanced by 9.53% to $4.2 million in 2024, then plunged by 75.62% to $1.0 million in 2025, then plunged by 40.71% to $603000.0 in 2026.
• Business Quant data shows GOSS's Other Non Operating Income at $603000.0 in Q1 2026, $1.0 million in Q4 2025, and $3.0 million in Q3 2025.